Select Sector SPDR Trust. Holdings as of Jun 30, 2026, from Form N-PORT.
Share of net assets at the report date, for the whole fund across all share classes.
| Holding | Weight | Value | Shares or units |
|---|---|---|---|
| Eli Lilly & CoLLY | 16.51% | $6.70B | 5,588,593 |
| Johnson & JohnsonJNJ | 10.64% | $4.32B | 17,006,170 |
| AbbVie IncABBV | 7.74% | $3.14B | 12,481,854 |
| UnitedHealth Group IncUNH | 6.57% | $2.67B | 6,415,798 |
| Merck & Co IncMRK | 5.52% | $2.24B | 17,448,577 |
| Amgen IncAMGN | 3.40% | $1.38B | 3,812,905 |
| Thermo Fisher Scientific IncTMO | 3.24% | $1.32B | 2,625,398 |
| Abbott LaboratoriesABT | 2.75% | $1.12B | 12,305,409 |
| Gilead Sciences IncGILD | 2.73% | $1.11B | 8,771,312 |
| Intuitive Surgical IncISRG | 2.45% | $995.03M | 2,502,083 |
| Pfizer IncPFE | 2.39% | $969.58M | 40,264,803 |
| CVS Health CorpCVS | 2.30% | $932.50M | 9,013,998 |
| Vertex Pharmaceuticals IncVRTX | 2.19% | $890.68M | 1,793,091 |
| Danaher CorpDHR | 2.09% | $847.68M | 4,450,208 |
| Bristol-Myers Squibb CoBMY | 2.05% | $831.26M | 14,426,589 |
| Stryker CorpSYK | 1.89% | $767.42M | 2,437,485 |
| Medtronic PLC | 1.75% | $709.56M | 9,070,237 |
| McKesson CorpMCK | 1.58% | $641.66M | 849,201 |
| Elevance Health IncELV | 1.46% | $593.33M | 1,534,224 |
| Cigna Group/TheCI | 1.27% | $515.19M | 1,868,792 |
| Boston Scientific CorpBSX | 1.10% | $448.17M | 10,500,647 |
| Regeneron Pharmaceuticals IncREGN | 1.08% | $440.15M | 705,889 |
| HCA Healthcare IncHCA | 1.05% | $427.73M | 1,097,065 |
| Cardinal Health IncCAH | 0.97% | $393.05M | 1,654,540 |
| Cencora IncCOR | 0.96% | $388.94M | 1,374,447 |
| Edwards Lifesciences CorpEW | 0.91% | $367.98M | 4,067,877 |
| Humana IncHUM | 0.83% | $336.89M | 848,128 |
| Becton Dickinson & CoBDX | 0.73% | $294.58M | 1,946,609 |
| IDEXX Laboratories IncIDXX | 0.72% | $293.35M | 557,240 |
| Agilent Technologies IncA | 0.65% | $265.19M | 1,996,497 |
| Waters CorpWAT | 0.64% | $260.13M | 693,612 |
| IQVIA Holdings IncIQV | 0.56% | $227.82M | 1,179,065 |
| Biogen IncBIIB | 0.56% | $225.35M | 1,042,998 |
| Zoetis IncZTS | 0.52% | $212.83M | 2,961,729 |
| Centene CorpCNC | 0.52% | $212.73M | 3,314,038 |
| GE HealthCare Technologies IncGEHC | 0.51% | $205.70M | 3,213,607 |
| ResMed IncRMD | 0.49% | $199.71M | 1,024,772 |
| Veeva Systems IncVEEV | 0.46% | $188.25M | 1,060,718 |
| Dexcom IncDXCM | 0.45% | $183.60M | 2,726,052 |
| Mettler-Toledo International IncMTD | 0.45% | $182.40M | 142,776 |
| West Pharmaceutical Services IncWST | 0.44% | $179.20M | 499,163 |
| Moderna IncMRNA | 0.43% | $174.71M | 2,494,789 |
| Quest Diagnostics IncDGX | 0.41% | $165.74M | 781,999 |
| Labcorp Holdings IncLH | 0.40% | $162.22M | 579,364 |
| STERIS PLC | 0.36% | $145.90M | 692,891 |
| Incyte CorpINCY | 0.33% | $134.39M | 1,185,538 |
| Viatris IncVTRS | 0.32% | $130.65M | 8,227,148 |
| Zimmer Biomet Holdings IncZBH | 0.29% | $117.66M | 1,366,745 |
| Cooper Cos Inc/TheCOO | 0.24% | $98.84M | 1,378,380 |
| State Street Global AdvisorsCash or money market | 0.23% | $95.26M | 95,263,137 |
Holdings from the fund's latest Form N-PORT; expense ratio (net of fee waivers) from the risk/return summary of its prospectus; fund type from Form N-CEN. Prices are end-of-day closes adjusted for splits; total return also reinvests distributions.